Attenuation of LPS-induced changes in synaptic activity in rat hippocampus by Vasogen's Immune Modulation Therapy

Systemic injection of lipopolysaccharide (LPS) blocks the expression of long-term potentiation in the hippocampus of the rat. This is coupled with increased IL-1beta concentration and c-Jun NH(2)-terminal kinase activity, as well as an increase in the number of cells displaying apoptotic characteris...

Full description

Saved in:
Bibliographic Details
Published inNeuroimmunomodulation Vol. 10; no. 1; p. 40
Main Authors Nolan, Yvonne, Minogue, Aedín, Vereker, Emily, Bolton, Anthony E, Campbell, Veronica A, Lynch, Marina A
Format Journal Article
LanguageEnglish
Published Switzerland 01.01.2002
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Systemic injection of lipopolysaccharide (LPS) blocks the expression of long-term potentiation in the hippocampus of the rat. This is coupled with increased IL-1beta concentration and c-Jun NH(2)-terminal kinase activity, as well as an increase in the number of cells displaying apoptotic characteristics in the hippocampus. Vasogen's Immune Modulation Therapy (IMT) is a procedure involving intramuscular administration of syngeneic blood which has been exposed ex vivo to elevated temperature, oxidation and ultraviolet light. We report that Vasogen's IMT significantly abrogates these LPS-induced effects with a concomitant increase in the concentration of the anti-inflammatory cytokine IL-10. These data suggest that Vasogen's IMT may play a protective role against the deleterious effects of immune insults in the brain.
ISSN:1021-7401
DOI:10.1159/000064413